Fu et al. [41] pointed out that miR-138 can inhibit the occurrence and development of psoriasis by targeting runt-related transcription factor 3 (RUNX3) and regulating the Th1/Th2 ratio in CD4+ T cells. The gene discussed is CD4; the disease is psoriasis.